Biliary polyunsaturated fatty acids and telocytes in gallstone disease

Cell Transplantation

Volumn 26, Issue 1, 2017, Pages 125-133

  Pasternak, Artur ^a   Bugajska, Jolanta ^a   Szura, Mirosław ^a   Walocha, Jerzy A ^a   Matyja, Andrzej ^a   Gajda, Mariusz ^a   Sztefko, Krystyna ^a   Gil, Krzysztof ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Bile lithogenicity; Biliary fatty acids; Cholesterol saturation index (CSI); Gallstones; Interstitial Cajal like cells; Polyunsaturated fatty acids (PUFAs); Telocytes (TCs)

Indexed keywords

1,2 DIPENTADECANOIL GLYCERO 3 PHOSPHOCHOLINE; ARACHIDONIC ACID; BILE ACID; BILE ACID CONJUGATE; CHOLESTEROL; DOCOSAHEXAENOIC ACID; EICOSADIENOIC ACID; FATTY ACID; GLYCOCHENODEOXYCHOLIC ACID; GLYCOCHOLIC ACID; GLYCODEOXYCHOLIC ACID; ICOSAPENTAENOIC ACID; LAURIC ACID; LINOLEIC ACID; LINOLENIC ACID; MONOUNSATURATED FATTY ACID; MYRISTIC ACID; OLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PALMITIC ACID; PALMITOLEIC ACID; PHOSPHOLIPID; SATURATED FATTY ACID; STEARIC ACID; TAUROCHENODEOXYCHOLIC ACID; TAUROCHOLIC ACID; TAURODEOXYCHOLIC ACID; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; BILE COMPOSITION; BILE TOXICITY; CELL COUNT; CELL DENSITY; CELL LOSS; CELL PROTECTION; CHOLESTEROL SATURATION INDEX; CHOLESTEROL STONE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EXTRAHEPATIC BILE DUCT; FATTY ACID ANALYSIS; FEMALE; GALLBLADDER; GALLBLADDER DISEASE; GALLBLADDER MOTILITY; GALLBLADDER MUSCLE; GALLSTONE; GALLSTONE FORMATION; HUMAN; HUMAN TISSUE; LIMIT OF QUANTITATION; LIPID COMPOSITION; MALE; MIDDLE AGED; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; TELOCYTE; TOXICITY; AGED; BILE; CHOLELITHIASIS; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY;

ADULT; AGED; BILE; CHOLELITHIASIS; FATTY ACIDS; FATTY ACIDS, UNSATURATED; FEMALE; GALLBLADDER; GALLSTONES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; TELOCYTES;

EID: 85010297578     PISSN: 09636897     EISSN: 15553892     Source Type: Journal    
DOI: 10.3727/096368916X692717     Document Type: Article

References (40)

1. Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: Cholelithiasis and cancer. Gut Liver 2012;6(2): 172–87.
2. Van Erpecum KJ. Pathogenesis of cholesterol and pigment gallstones: An update. Clin Res Hepatol Gastroenterol. 2011;35:281–7.
3. Matyja A, Gil K, Pasternak A, Sztefko K, Gajda M, Tomaszewski KA, Matyja M, Walocha JA, Kulig J, Thor P. Telocytes: New insight into the pathogenesis of gallstone disease. J Cell Mol Med. 2013;17(6):734–42.
4. Diehl AK. Epidemiology and natural history of gallstone disease. Gastroenterol Clin North Am. 1991;20:1–19.
5. Mendez-Sanchez N, Zamora-Valdes D, Chavez-Tapia NC, Uribe M. Role of diet in cholesterol gallstone formation. Clin Chim Acta 2007;376:1–8.
6. Méndez-Sánchez N, González V, Aguayo P, Sánchez JM, Tanimoto MA, Elizondo J, Uribe M. Fish oil (n-3) polyunsaturated fatty acids beneficially affect biliary cholesterol nucleation time in obese women losing weight. J Nutr. 2001;131(9):2300–3.
7. Kim JK, Cho SM, Kang SH, Kim E, Yi H, Yun ES, Lee DG, Cho HJ, Paik YH, Choi YK, Haam SJ, Shin HC, Lee DK. N-3 polyunsaturated fatty acid attenuates cholesterol gallstones by suppressing mucin production with a high cholesterol diet in mice. J Gastroenterol Hepatol. 2012; 27(11):1745–51.
8. Hull MA. Omega-3 polyunsaturated fatty acids. Best Pract Res Clin Gastroenterol. 2011;25:547–54.
9. Lee DK, Jang SI. Can fish oil dissolve gallstones? J Gastroenterol Hepatol. 2012;27(11):1649–51.
10. LaMorte WW, O’Leary DP, Booker ML, Scott TE. Increased dietary fat content accelerates cholesterol gallstone formation in the cholesterol-fed prairie dog. Hepatology 1993;18(6):1498–503.
11. Pomeranz IS, Shaffer EA. Abnormal gallbladder emptying in a subgroup of patients with gallstones. Gastroenterology 1985;88:787–91.
12. Sharma BC, Agarwal DK, Dhiman RK, Baijal SS, Choudhuri G, Saraswat VA. Bile lithogenicity and gallbladder emptying in patients with microlithiasis: Effect of bile acid therapy. Gastroenterology 1998;115:124–8.
13. Portincasa P, Di Ciaula A, Vendemiale G, Palmieri V, Moschetta A, Vanberge-Henegouwen GP, Palasciano G. Gallbladder motility and cholesterol crystallization in bile from patients with pigment and cholesterol gallstones. Eur J Clin Invest. 2000;30:317–24.
14. Cretoiu SM, Popescu LM. Telocytes revisited. Biomol Concepts 2014;5(5):353–69.
15. Gherghiceanu M, Popescu LM. Cardiac telocytes—Their junctions and functional implications. Cell Tissue Res. 2012;348:265–79.
16. Popescu LM, Manole E, Serboiu CS, Manole CG, Suciu LC, Gherghiceanu M, Popescu BO. Identification of telocytes in skeletal muscle interstitium: Implication for muscle regeneration. J Cell Mol Med. 2011;15:1379–92.
17. Hinescu ME, Ardeleanu C, Gherghiceanu M, Popescu LM. Interstitial Cajal-like cells in human gallbladder. J Mol Histol. 2007;38:275–84.
18. Pasternak A, Gil K, Matyja A, Gajda M, Sztefko K, Walocha JA, Kulig J, Thor P. Loss of gallbladder interstitial Cajal-like cells in patients with cholelithiasis. Neurogastroenterol Motil. 2013;25:e17–24.
19. Carey MC, Small DM. The physical chemistry of cholesterol solubility in bile. J Clin Invest. 1978;61:998–1026.
20. Carey MC. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res. 1978;19:945–55
21. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226(1):497–509.
22. Kaluzny MA, Duncan LA, Merritt MV, Epps DE. Rapid separation of lipid classes in high yield and purity using bonded phase columns. J Lipid Res. 1985;26(1):135–40.
23. Morrison WR, Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride— Methanol. J Lipid Res. 1964;5:600–8.
24. Kang JX, Wang J. A simplified method for analysis of polyunsaturated fatty acids. BMC Biochem. 2005;6:5.
25. Magnuson TH, Lillemoe KD, High RC, Pitt HA. Dietary fish oil inhibits cholesterol monohydrate crystal nucleation and gallstone formation in the prairie dog. Surgery 1995;118:517–23.
26. Misciagna G, Centonze S, Leoci C, Guerra V, Cisternino AM, Ceo R, Trevisan M. Diet, physical activity, and gallstones— A population-based, case-control study in southern Italy. Am J Clin Nutr. 1999;69:120–6.
27. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Long-term intake of trans-fatty acids and risk of gallstone disease in men. Arch Intern Med. 2005;165:1011–5.
28. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Long-chain saturated fatty acids consumption and risk of gallstone disease among men. Ann Surg. 2008;247:95–103.
29. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. The effect of long-term intake of cis unsaturated fats on the risk for gallstone disease in men: A prospective cohort study. Ann Intern Med. 2004;141:514–22.
30. Rotstein OD, Kay RM, Wayman M, Strasberg SM. Prevention of cholesterol gallstones by lignin and lactulose in the hamster. Gastroenterology 1981;81:1098–103.
31. Robins SJ, Fasulo J. Mechanism of lithogenic bile production: Studies in the hamster fed an essential fatty acid-deficient diet. Gastroenterology 1973;65:104–14.
32. Berr F, Holl J, Jungst D, Fischer S, Richter WO, Seifferth B, Paumgartner G. Dietary n-3 polyunsaturated fatty acids decrease biliary cholesterol saturation in gallstone disease. Hepatology 1992;16:960–7.
33. El-Badry AM, Graf R, Clavien PA. Omega 3–Omega 6: What is right for the liver? J Hepatol. 2007;47(5):718–25.
34. Simopoulos AP. Essential fatty acids in health and chronic diseases. Forum Nutr. 2003;56:67–70.
35. Portincasa P, Di Ciaula A, Vendemiale G, Palmieri V, Moschetta A, Vanberge-Henegouwen GP, Palasciano G. Gallbladder motility and cholesterol crystallization in bile from patients with pigment and cholesterol gallstones. Eur J Clin Invest. 2000;30:317–24.
36. Pasternak A, Gil K, Matyja A, Gajda M, Sztefko K, Walocha JA, Kulig J, Thor P. Loss of gallbladder interstitial Cajal-like cells in patients with cholelithiasis. Neurogastroenterol Motil. 2013;25:e17–24.
37. Aleksandrovych V, Walocha JA, Gil K. Telocytes in female reproductive system (human and animal). J Cell Mol Med. 2016;20(6):994–1000.
38. Xu QW, Shaffer EA. The potential site of impaired gallbladder contractility in an animal model of cholesterol gallstone disease. Gastroenterology 1996;110:251–7.
39. Lavoie B, Nausch B, Zane EA, Leonard MR, Balemba OB, Bartoo AC, Wilcox R, Nelson MT, Carey MC, Mawe GM. Disruption of gallbladder smooth muscle function is an early feature in the development of cholesterol gallstone disease. Neurogastroenterol Motil. 2012;24:e313–24.
40. Lavoie B, Balemba OB, Nelson MT, Ward SM, Mawe GM. Morphological and physiological evidence for interstitial cell of Cajal-like cells in the guinea pig gallbladder. J Physiol. 2007;579:487–501.